sábado, 7 de mayo de 2016

Calls to augment 14-day embryo rule

Calls to augment 14-day embryo rule



Calls to extend 14-day embryo rule
     


Policy analysts in the US and UK are calling for an augmentation of the decades-old 14-day embryo experimentation rule – a regulation that requires scientists to terminate any embryo in vitro before it reaches two weeks of development.

The calls for change have come in the wake of the publication of ground-breaking embryology research in Nature journals this week.

In two separate studies scientists have reported keeping embryos alive, healthy and developing up until the 14-day mark. In both studies the embryos grew autonomously and began processes that lead to organ development –a major improvement on any previous in vitro experiment.

University of Manchester bioethicist John Harris argued in The Guardian that A switch to a 21-day deadline would allow scientists to better understand miscarriages and the possibilities of using stem cells to treat diseases:

“The overwhelming consensus of scientific opinion, as of this week, is that much of considerable scientific and therapeutic importance can be learned by extending the 14-day limit for a further week, to 21 days…”.
Harris suggested that the original rule was based on an arcane and outmoded value system.

The Nuffield Council on Bioethics published a press release indicating that they are currently considering whether to advocate for a change in the law. The Council is set to hold a colloquium later this year bringing together “invited participants with a range of perspectives on embryo research in order to evaluate whether, after 25 years, there may be persuasive reasons to review this legal limit”.

A group of influential US ethicists writing in Nature this week called for both clarification and re-evaluation of existing regulations:

“Now that the culturing of human embryos beyond 14 days seems feasible, more clarity as to how the rule applies to different types of embryo research in different jurisdictions is crucial. Moreover, in light of the evolving science and its potential benefits, it is important that regulators and concerned citizens reflect on the nature of the restriction and re-evaluate its pros and cons.”
Reverend Tadeusz Pacholczyk of the National Catholic Bioethics Center offered an alternatively perspective and suggested that the 14-day-rule was flawed to begin with.  The arbitrary rule only paid “lip service to the moral status of the human embryo”, Pacholczyk said.
- See more at: http://www.bioedge.org/bioethics/calls-to-augment-14-day-embryo-rule/11867#sthash.jf2hxzMe.dpuf





Bioedge



BioEdge was launched in 2001, in the week that President George W. Bush announced his administration's policy on human embryonic stem cell research. That fuelled a huge debate about a field of science which very few people had ever heard of, let alone thought deeply about. Ever since we've been chronicling the debates surrounding the ever-expanding empire of bioethics. 
As we celebrate our 15th anniversary, we are also promoting a fund-raising drive over the next four weeks. The BioEdge newsletter is free, but it is increasingly expensive to produce. This year we are hoping to raise $15,000. 
Cheers,


Michael Cook
Editor
BioEdge

This week in BioEdge
 
by Xavier Symons | May 07, 2016
Policy analysts in the US and UK are calling for an augmentation of the decades-old 14-day embryo experimentation rule.
 
by Michael Cook | May 07, 2016
Steep rise in end-stage psychiatric disorders and dementia.
 
by Xavier Symons | May 07, 2016
Public health executives see a big positive in the US opioid tragedies – increased organ donation.
 
by Xavier Symons | May 07, 2016
Here’s what a few bioethicists have to say.
 
by Xavier Symons | May 07, 2016
Human beings are more likely to die in a mass extinction event than a car crash, according to a new report on existential risk.
 
by Michael Cook | May 07, 2016
... but supports altruistic surrogacy
 
by Michael Cook | May 07, 2016
Falun Gong supporters query government announcements
 
by Michael Cook | May 07, 2016
Proof-of-concept clinical trials on 20 patients in India
 
by Michael Cook | May 07, 2016
Overwhelmingly against germline modification
BioEdge
Suite 12A, Level 2 | 5 George St | North Strathfield NSW 2137 | Australia
Phone: +61 2 8005 8605
Mobile: 0422-691-615
New Media Foundation | Level 2, 5 George St | North Strathfield NSW 2137 | AUSTRALIA | +61 2 8005 8605 

Bioedge

No hay comentarios: